Published in Phytomedicine on December 01, 1998
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage (2002) 3.88
The functional neuroanatomy of target detection: an fMRI study of visual and auditory oddball tasks. Cereb Cortex (1999) 2.15
Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease. J Neurol Neurosurg Psychiatry (2004) 2.12
Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease. Neurology (2012) 1.78
Resting-state EEG in schizophrenia: auditory verbal hallucinations are related to shortening of specific microstates. Clin Neurophysiol (2010) 1.62
Psychosocial work factors and dementia. Occup Environ Med (2004) 1.62
Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study. Mol Psychiatry (2008) 1.54
1.3 A structure of arylsulfatase from Pseudomonas aeruginosa establishes the catalytic mechanism of sulfate ester cleavage in the sulfatase family. Structure (2001) 1.49
The iron sulfur protein AtsB is required for posttranslational formation of formylglycine in the Klebsiella sulfatase. J Biol Chem (1999) 1.46
IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease. Neurology (2007) 1.45
BOLD correlates of EEG alpha phase-locking and the fMRI default mode network. Neuroimage (2009) 1.43
[Mild cognitive impairment with predictors of rapid decline]. Dtsch Med Wochenschr (2008) 1.39
[New options for the pharmacotherapy of Alzheimer's disease after the registration of memantine?]. Dtsch Med Wochenschr (2005) 1.39
Mutations in a polycistronic nuclear gene associated with molybdenum cofactor deficiency. Nat Genet (1998) 1.38
Decreased EEG synchronization in Alzheimer's disease and mild cognitive impairment. Neurobiol Aging (2005) 1.37
Discrimination of Alzheimer's disease and mild cognitive impairment by equivalent EEG sources: a cross-sectional and longitudinal study. Clin Neurophysiol (2000) 1.37
Functional imbalance of visual pathways indicates alternative face processing strategies in autism. Neurology (2003) 1.35
Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type. J Psychiatr Res (1998) 1.21
Effects of arousing emotional scenes on the distribution of visuospatial attention: changes with aging and early subcortical vascular dementia. J Neurol Sci (2004) 1.19
Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing. Exp Neurol (2009) 1.17
The practice of obtaining approval from medical research ethics committees: a comparison within 12 European countries for a descriptive study on acetylcholinesterase inhibitors in Alzheimer's dementia. Eur J Neurol (2005) 1.15
Alzheimer's Disease Assessment Scale: reliability and validity in a multicenter clinical trial. Int Psychogeriatr (1997) 1.11
Functional imaging of visuospatial processing in Alzheimer's disease. Neuroimage (2002) 1.11
Application of high-throughput technologies to a structural proteomics-type analysis of Bacillus anthracis. Acta Crystallogr D Biol Crystallogr (2006) 1.11
A novel protein modification generating an aldehyde group in sulfatases: its role in catalysis and disease. Bioessays (1998) 1.11
Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques. Neurosci Lett (1999) 1.08
A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI. Neurology (2009) 1.05
Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment. J Nutr Health Aging (2009) 1.04
Ginkgo biloba extract EGb 761(R), donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: a randomised, double-blind, exploratory trial. Aging Ment Health (2009) 1.03
Plasticity in the adult language system: a longitudinal electrophysiological study on second language learning. Neuroimage (2006) 1.02
Crystal structure of an enzyme-substrate complex provides insight into the interaction between human arylsulfatase A and its substrates during catalysis. J Mol Biol (2001) 1.01
Amino acid residues forming the active site of arylsulfatase A. Role in catalytic activity and substrate binding. J Biol Chem (1999) 0.99
Differential validity of psychometric tests in dementia of the Alzheimer type. Psychiatry Res (1992) 0.98
Residues critical for formylglycine formation and/or catalytic activity of arylsulfatase A. Biochemistry (1998) 0.97
Stage-dependent reductions of regional cerebral blood flow measured by HMPAO-SPECT in dementia of Alzheimer type. Psychiatry Res (1989) 0.96
Cerebral blood flow identifies responders to transcranial magnetic stimulation in auditory verbal hallucinations. Transl Psychiatry (2012) 0.96
Effects of weak mobile phone - electromagnetic fields (GSM, UMTS) on event related potentials and cognitive functions. Bioelectromagnetics (2008) 0.95
Dementia of the Alzheimer type: effects on the spontaneous EEG described by dipole sources. Psychiatry Res (1993) 0.94
Time course of blood oxygenation level-dependent signal response after theta burst transcranial magnetic stimulation of the frontal eye field. Neuroscience (2007) 0.94
Sulfatases, trapping of the sulfated enzyme intermediate by substituting the active site formylglycine. J Biol Chem (1998) 0.94
Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type. J Neurochem (1995) 0.94
[The effect of psychosocial factors on risk of dementia]. Fortschr Neurol Psychiatr (2002) 0.93
Arylsulfatase from Klebsiella pneumoniae carries a formylglycine generated from a serine. J Biol Chem (1998) 0.92
P300 asymmetries in schizophrenia revisited with reference-independent methods. Psychiatry Res (1994) 0.92
White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study. J Neurol Neurosurg Psychiatry (2009) 0.92
EEG and auditory evoked potential P300 compared with psychometric tests in assessing vigilance after benzodiazepine sedation and antagonism. Br J Anaesth (1992) 0.91
Event-related potentials and psychopharmacology. Cholinergic modulation of P300. Pharmacopsychiatry (1994) 0.90
Multimodal imaging of residual function and compensatory resource allocation in cortical atrophy: a case study of parietal lobe function in a patient with Huntington's disease. Psychiatry Res (1999) 0.90
EEG-correlates of facial affect recognition and categorisation of blurred faces in schizophrenic patients and healthy volunteers. Schizophr Res (2001) 0.89
Selective binding of soluble Abeta1-40 and Abeta1-42 to a subset of senile plaques. Am J Pathol (1996) 0.89
The experimental combination of rTMS and fMRI reveals the functional relevance of parietal cortex for visuospatial functions. Brain Res Cogn Brain Res (2002) 0.88
Topography of the quantitative electroencephalogram in dementia of the Alzheimer type: relation to severity of dementia. Psychiatry Res (1991) 0.88
Multilead quantitative electroencephalogram profile and cognitive evoked potentials (P300) in healthy subjects after a single dose of olanzapine. Psychopharmacology (Berl) (2001) 0.87
Enhanced ROS-generation in lymphocytes from Alzheimer's patients. Pharmacopsychiatry (2005) 0.87
Hallucinations, thought disorders, and the language domain in schizophrenia. Clin EEG Neurosci (2008) 0.87
Reaction mechanism of the reconstituted oxoglutarate carrier from bovine heart mitochondria. Eur J Biochem (1991) 0.86
Reaction mechanism of the reconstituted tricarboxylate carrier from rat liver mitochondria. Biochim Biophys Acta (1993) 0.86
Characterization of posttranslational formylglycine formation by luminal components of the endoplasmic reticulum. J Biol Chem (2001) 0.86
Functional imaging procedures in dementias: mapping of EEG and evoked potentials. Acta Neurol Scand Suppl (1992) 0.86
Progression of Alzheimer disease in Europe: data from the European ICTUS study. Curr Alzheimer Res (2012) 0.85
A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI. J Nutr Health Aging (2012) 0.85
Effects of weak mobile phone - electromagnetic fields (GSM, UMTS) on well-being and resting EEG. Bioelectromagnetics (2008) 0.85
A comparison of qEEG and HMPAO-SPECT in relation to the clinical severity of Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci (1997) 0.83
Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders? J Neural Transm Suppl (1995) 0.83
[Creative therapy options for patients with dementia--a systematic review]. Fortschr Neurol Psychiatr (2006) 0.83
Integrity of the blood-CSF barrier in dementia of Alzheimer type: CSF/serum ratios of albumin and IgG. Eur Arch Psychiatry Clin Neurosci (1991) 0.83
Electrophysiological correlates of emotional and structural face processing in humans. Neurosci Lett (2000) 0.83
Apoptosis of CD4+ T and natural killer cells in Alzheimer's disease. Pharmacopsychiatry (2006) 0.82
Larger topographical variance and decreased duration of brain electric microstates in depression. J Neural Transm Gen Sect (1995) 0.82
Mefloquine-induced paranoid psychosis and subsequent major depression in a 25-year-old student. Pharmacopsychiatry (2002) 0.82
Venlafaxin-associated post-ictal asystole during electroconvulsive therapy. Pharmacopsychiatry (2011) 0.82
[Attitudes towards predictive genetic testing for Alzheimer's disease]. Z Gerontol Geriatr (2006) 0.82
Reduced immunoreactivity of adenylyl cyclase in dementia of the Alzheimer type. Neuroreport (1996) 0.82
P3 topography in psychiatry and psychopharmacology. Brain Topogr (1990) 0.81
The clinical utility of structural neuroimaging with MRI for diagnosis and differential diagnosis of dementia: a memory clinic study. Int J Geriatr Psychiatry (2005) 0.81
Topography of the maximum of the amplitude of EEG frequency bands in dementia of the Alzheimer type. Biol Psychiatry (1996) 0.81
Luciferase assembly after transport into mammalian microsomes involves molecular chaperones and peptidyl-prolyl cis/trans-isomerases. J Biol Chem (1996) 0.81
[Topography of P300 in psychiatry--1. Cognitive P300 fields in psychoses]. EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb (1988) 0.81
Correlation between cognitive brain function and electrical brain activity in dementia of Alzheimer type. J Neural Transm Gen Sect (1995) 0.81
Decline and preservation of reversal learning abilities and acquisition in the course of senescence. Neurosci Lett (1995) 0.80
EEG slowing and cerebrospinal fluid tau levels in patients with cognitive decline. Neuroreport (1998) 0.80
The fuzzy frontier between subjective memory complaints and early dementia. A survey of patient management in German memory clinics. Dement Geriatr Cogn Disord (2004) 0.80
Subclinical hyperthyroidism in dementia and correlation of the metabolic index in FDG-PET. Acta Med Austriaca (2003) 0.80
Efficient folding of firefly luciferase after transport into mammalian microsomes in the absence of luminal chaperones and folding catalysts. J Biol Chem (1996) 0.80
The mitochondrial carnitine carrier: characterization of SH-groups relevant for its transport function. Biochim Biophys Acta (1992) 0.80
Schizophrenia-like psychosis associated with an arachnoid cyst visualized by mapping of EEG and P300. Psychiatry Res (1989) 0.79
Cyclosporin A inhibits the degradation of signal sequences after processing of presecretory proteins by signal peptidase. Eur J Biochem (1996) 0.79
Reduced immunoreactivity of type I adenylyl cyclase in the postmortem brains of alcoholics. Alcohol Clin Exp Res (1998) 0.79
Cerebral hemodynamic response induced by the Tower of Hanoi puzzle and the Wisconsin Card Sorting test. Neuropsychologia (2002) 0.79